Celltrion
068270.KS
#754
Rank
โ‚น2.933 T
Marketcap
โ‚น13,410
Share price
1.40%
Change (1 day)
31.65%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: โ‚น2.933 Trillion

As of February 2026 Celltrion has a market cap of โ‚น2.933 Trillion. This makes Celltrion the world's 754th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚น2.933 T19.76%
2025โ‚น2.449 T8.22%
2024โ‚น2.263 T-18.78%
2023โ‚น2.787 T85.78%
2022โ‚น1.500 T-13.07%
2021โ‚น1.725 T-47.67%
2020โ‚น3.297 T132.25%
2019โ‚น1.419 T-18.24%
2018โ‚น1.736 T5.66%
2017โ‚น1.643 T122.48%
2016โ‚น738.73 B37.54%
2015โ‚น537.10 B134%
2014โ‚น229.53 B4.15%
2013โ‚น220.37 B-7.37%
2012โ‚น237.92 B23.17%
2011โ‚น193.16 B25.04%
2010โ‚น154.47 B152.45%
2009โ‚น61.19 B57.84%
2008โ‚น38.76 B5187.57%
2007โ‚น0.73 B